Health and Human Services Secretary Robert F. Kennedy Jr. testified before congressional committees this week, enduring sustained questioning from Democratic members over vaccine safety messaging, deep cuts to federal public health agencies, and his department's broader policy agenda. The hearings marked one of Kennedy's most high-profile appearances before Congress since taking office.

Democratic lawmakers pressed Kennedy repeatedly on his past statements questioning vaccine efficacy and safety, as well as on the practical impact of staffing reductions at agencies including the CDC and FDA. Kennedy defended the administration's approach, arguing that the cuts were necessary to reduce bureaucratic inefficiency and that his Make America Healthy Again initiative represented a positive shift in national health priorities.

The hearings also touched on the role of CDC Director Dr. Susan Schwartz, whose position and relationship with Kennedy's broader agenda drew scrutiny from members on both sides of the aisle. Questions about the scientific independence of public health agencies surfaced repeatedly during the proceedings.

Republican committee members largely offered Kennedy a more favorable reception, framing his tenure as a needed disruption to entrenched health bureaucracies and praising efforts to address chronic disease and nutrition. The contrast in tone between Democratic and Republican questioning was stark throughout both days of testimony.

The hearings unfolded against a backdrop of ongoing debate about the administration's approach to public health infrastructure, with several advocacy groups and former agency officials raising concerns about institutional capacity ahead of the testimony.